ALVO vs Peers Stock Comparison

Alvotech Prices as of Oct 26, 2026 Peers: Industry group
ALVO Alvotech
$4.62 -19.7% 1M -45.0% 1Y
Market cap
$1.44B
P/E
–
Revenue (TTM)
$105.94M
Div. yield
–
Generic Drugs Healthcare

Percentile Scorecard

ALVO

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisALVO
Valuation 76 #67 of 275
Growth 35 #166 of 253
Profitability 68 #73 of 224
Financial Health 25 #223 of 296
Shareholder Returns –
Overall 51
  • ALVO ranked among 305 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodALVOSPY
1 month -19.7% -0.8%
3 months +50.0% +3.5%
6 months +40.0% +7.0%
Year to date -9.9% +12.2%
1 year -45.0% +13.0%
3 years -48.6% +86.3%
3 years, per year -19.9% +23.1%
5 years -53.3% +68.6%
5 years, per year -14.1% +11.0%

Risk

MeasureALVOSPY
Volatility, 1Y 81.8% 12.7%
Downside volatility, 1Y 86.1% 12.7%
Beta vs S&P 500, 1Y 0.73 1.00
Return / volatility, 1Y -0.55 1.02
Max drawdown, 5Y -82.6% -25.4%
From 52-week high -43.2% -1.8%
52-week high $8.13 $779.14
52-week low $3.00 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleALVO
P/E now vs peer median -5.1xmedian 10.4x
P/S now vs peer median 13.6xmedian 6.4x
EV/EBITDA now vs peer median 29.3xmedian 10.7x
P/FCF now vs peer median -5.5xmedian 12.5x
P/B now vs peer median -7.5xmedian 1.6x
PEG now vs peer median -0.21median 0.29

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsALVO
Revenue $105.94M
Gross profit $7.66M
Operating income $47.54M
Net income -$179.60M
Free cash flow -$261.39M
R&D $46.37M
EPS (diluted) $-0.90
Cash & equivalents $142.80M
Total debt $1.31B
Shares (diluted) 291.34M
Enterprise value $1.01B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricALVO
P/E -5.1x
P/FCF -5.5x
P/Operating cash flow -7.3x
P/S 13.6x
P/B -7.5x
P/Tangible book -4.3x
EV/EBITDA 29.3x
EV/EBIT 54.8x
EV/Revenue 24.6x
EV/FCF -10.0x
EV/Operating cash flow -13.1x
PEG (3Y EPS CAGR) -0.21

Growth

14 metrics
MetricALVO
Revenue growth (1Y) -74.3%
Revenue CAGR (3Y) 104.2%
Gross profit growth (1Y) -95.0%
Gross profit CAGR (3Y) 27.6%
Operating income growth (1Y) -13.3%
Operating income CAGR (3Y) 28.9%
Net income growth (1Y) -383.6%
Net income CAGR (3Y) 24.4%
EPS growth (1Y) -481.6%
EPS CAGR (3Y) 24.6%
Operating cash flow growth (1Y) -367.1%
Operating cash flow CAGR (3Y) 12.8%
Free cash flow growth (1Y) -113.0%
Free cash flow CAGR (3Y) 8.6%

Profitability

14 metrics
MetricALVO
Gross margin 7.2%
EBITDA margin 83.9%
Operating margin 44.9%
Pretax margin -62.1%
Net margin -248.0%
FCF margin -246.7%
Operating cash flow margin -187.6%
Return on equity –
Return on assets -17.5%
Return on invested capital 4.4%
Return on capital employed 4.1%
Asset turnover 0.1x
Cash conversion (OCF / net income) 1.1x
Stock comp / revenue 8.7%

Financial Health

11 metrics
MetricALVO
Debt / assets 82.3%
Debt / equity -6.8x
Net debt / EBITDA 13.1x
Debt / FCF -5.0x
Liabilities / assets 112.1%
Equity / assets -12.1%
Interest coverage 0.8x
Current ratio 1.6x
Quick ratio 1.1x
Cash ratio 0.4x
Altman Z-score -1.37

Shareholder Returns

7 metrics
MetricALVO
Dividend yield –
Net buyback yield –
Shareholder yield –
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusALVO
EPS, next fiscal year $-0.02FY2026
Revenue, next fiscal year $588.58MFY2026
Revenue growth, next FY -0.8%FY2026
Revenue growth, the year after +22.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersALVO
Held by institutions 14.7%
Institutions holding 72
Change in shares held, QoQ +152.4%
Institutions buying 44
Institutions selling 17
Buyers to sellers 2.59

Add a Peer

Largest companies in the same industry

Related Comparisons

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.